IL6 and peeling skin syndrome: More recently, B7/H3 was also found to be upregulated on SG EC in pSS patients, promoting inflammation by activating the NF-κB pathway which results in increased levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNFα) enhancing the apoptosis of SG EC (27).